Elevance Health Inc. (ELV) Earnings Per Share (EPS): 23.51
Is Elevance Health Inc.’s earnings per share (EPS) high or low?
Elevance Health Inc.'s earnings per share (EPS) of 23.51 is in line with its 5-year average of 24.07, around the middle of its 5-year range (18.23–25.81).
The earnings per share (EPS) for Elevance Health Inc. (ELV) is 23.51 as of Wednesday, June 10, 2026. It is below its 12-month average by 7.79% (25.49).
ELV Earnings Per Share (EPS) Chart
ELV Average Earnings Per Share (EPS) Chart
ELV Current vs Average Earnings Per Share (EPS) Chart
ELV Earnings Per Share (EPS) Metrics
EARNINGS PER SHARE (EPS)
23.51
EARNINGS PER SHARE (EPS) AVG TTM
25.49
EARNINGS PER SHARE (EPS) AVG 3Y
25.23
EARNINGS PER SHARE (EPS) AVG 5Y
24.07
EARNINGS PER SHARE (EPS) AVG 10Y
19.23
EARNINGS PER SHARE (EPS) AVG 15Y
15.84
EARNINGS PER SHARE (EPS) AVG 20Y
13.47
CURRENT VS TTM AVG
-7.79%
CURRENT VS 3Y AVG
-6.83%
CURRENT VS 5Y AVG
-2.32%
CURRENT VS 10Y AVG
+22.23%
CURRENT VS 15Y AVG
+48.40%
CURRENT VS 20Y AVG
+74.57%
ELV Competitors' Earnings Per Share (EPS)
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elevance Health Inc. (ELV) | — | 23.51 | 25.49 | 25.23 | 24.07 |
| Cigna Corporation (CI) | $78.25B | 23.58 | 17.27 | 18.45 | 18.81 |
| Medtronic plc (MDT) | $103.04B | 3.73 | 3.69 | 3.25 | 3.23 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 16.86 | 6.69 | 10.10 | 9.99 |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 41.04 | 41.98 | 40.38 | 45.10 |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 3.56 | -0.48 | 1.47 | 0.84 |
| CVS Health Corporation (CVS) | $125.16B | 2.27 | 2.53 | 3.71 | 4.39 |
| Danaher Corporation (DHR) | $130.25B | 5.17 | 5.20 | 6.66 | 6.73 |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 13.56 | 11.97 | 10.56 | 9.63 |
| Humana Inc. (HUM) | $43.78B | 9.35 | 9.94 | 15.54 | 18.41 |
EPS Comparison
Trailing EPS (TTM)
$23.51
Forward EPS (Est.)
$29.24
P/E Ratio
17.1
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
- Directly impacts stock valuation through P/E ratio
- Used to calculate dividend coverage and payout ratios
- Enables comparison across companies of different sizes
- Growth in EPS often correlates with stock price appreciation
Elevance Health Inc. Earnings Per Share (EPS) Formula & Definition
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Elevance Health Inc. Earnings Per Share (EPS) FAQ
- What is the earnings per share (EPS) for Elevance Health Inc. (ELV)?
- The earnings per share (EPS) for ELV stock is 23.51.
- Is Elevance Health Inc.'s earnings per share (EPS) high or low?
- Elevance Health Inc.'s earnings per share (EPS) of 23.51 is in line with its 5-year average of 24.07, around the middle of its 5-year range (18.23–25.81).
- What is the TTM average earnings per share (EPS) for Elevance Health Inc. (ELV)?
- The TTM average earnings per share (EPS) for ELV stock is 25.49.
- What is the 3Y average earnings per share (EPS) for Elevance Health Inc. (ELV)?
- The 3Y average earnings per share (EPS) for ELV stock is 25.23.
- What is the 5Y average earnings per share (EPS) for Elevance Health Inc. (ELV)?
- The 5Y average earnings per share (EPS) for ELV stock is 24.07.
- What is the 10Y average earnings per share (EPS) for Elevance Health Inc. (ELV)?
- The 10Y average earnings per share (EPS) for ELV stock is 19.23.
- What is the 15Y average earnings per share (EPS) for Elevance Health Inc. (ELV)?
- The 15Y average earnings per share (EPS) for ELV stock is 15.84.
- What is the 20Y average earnings per share (EPS) for Elevance Health Inc. (ELV)?
- The 20Y average earnings per share (EPS) for ELV stock is 13.47.
Elevance Health Inc. Earnings Per Share (EPS) History
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 25.18 |
| 2024-12-31 | 25.81 |
| 2023-12-31 | 25.38 |
| 2022-12-31 | 24.56 |
| 2021-12-31 | 25.25 |
| 2020-12-31 | 18.23 |
| 2019-12-31 | 18.81 |
| 2018-12-31 | 14.53 |
| 2017-12-31 | 14.70 |
| 2016-12-31 | 9.39 |
| 2015-12-31 | 9.73 |
| 2014-12-31 | 9.31 |
| 2013-12-31 | 8.89 |
| 2012-12-31 | 8.26 |
| 2011-12-31 | 7.80 |
| 2010-12-31 | 7.64 |
| 2009-12-31 | 9.96 |
| 2008-12-31 | 4.79 |
| 2007-12-31 | 5.64 |
| 2006-12-31 | 4.93 |
| 2005-12-31 | 4.03 |
| 2004-12-31 | 3.15 |
| 2003-12-31 | 2.80 |
| 2002-12-31 | 2.31 |
| 2001-12-31 | 1.66 |
| 2000-12-31 | 1.10 |
| 1999-12-31 | 0.22 |
| 1998-12-31 | 0.84 |
Related Metrics
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux